PSMA-PET and SOC MRI for Prostate Cancer

Phase-Based Progress Estimates
1
Effectiveness
2
Safety
Prostate CancerPSMA-PET and SOC MRI - DiagnosticTest
Eligibility
Any Age
Male
What conditions do you have?
Select

Study Summary

This trial will test whether adding a PSMA PET scan to the standard of care MRI scan before surgery helps doctors better understand the cancer and leads to better patient outcomes.

Eligible Conditions
  • Prostate Cancer

Treatment Effectiveness

Effectiveness Progress

1 of 3

Similar Trials

1
Flutamide
1
Pelvic DCFPyL PET-MRI fusion or PET/MRI
1
PET/MRI

Study Objectives

1 Primary · 9 Secondary · Reporting Duration: 18 months

1 month
Therapeutic procedure
EPE detection
Ratio of positive surgical margins to nerve bundles spared
Surgical margins
18 months
Erectile dysfunction: ability to achieve erection sufficient for penetration
IIEF-EF sub scale score
Incontinence bother
Incontinence: using 0-1 pads per day
Overall mental and physical health
Urgency/frequency

Trial Safety

Safety Progress

2 of 3
This is further along than 68% of similar trials

Similar Trials

1
Flutamide
1
Pelvic DCFPyL PET-MRI fusion or PET/MRI
1
PET/MRI

Trial Design

2 Treatment Groups

SOC MRI prior to surgery
1 of 2
PSMA-PET and SOC MRI prior to surgery
1 of 2

Active Control

Experimental Treatment

288 Total Participants · 2 Treatment Groups

Primary Treatment: PSMA-PET and SOC MRI · No Placebo Group · Phase 2 & 3

PSMA-PET and SOC MRI prior to surgery
DiagnosticTest
Experimental Group · 1 Intervention: PSMA-PET and SOC MRI · Intervention Types: DiagnosticTest
SOC MRI prior to surgery
DiagnosticTest
ActiveComparator Group · 1 Intervention: SOC MRI · Intervention Types: DiagnosticTest

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: 18 months

Who is running the clinical trial?

Five Eleven Pharma, Inc.Lead Sponsor
5 Previous Clinical Trials
122 Total Patients Enrolled
3 Trials studying Prostate Cancer
104 Patients Enrolled for Prostate Cancer
Indiana UniversityOTHER
876 Previous Clinical Trials
749,288 Total Patients Enrolled
6 Trials studying Prostate Cancer
297 Patients Enrolled for Prostate Cancer
Clinton Bahler, MDPrincipal InvestigatorIndiana University School of Medicine
1 Previous Clinical Trials
36 Total Patients Enrolled
1 Trials studying Prostate Cancer
36 Patients Enrolled for Prostate Cancer

Eligibility Criteria

Age Any Age · Male Participants · 4 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You have no erectile dysfunction, mild erectile dysfunction, or mild-to-moderate erectile dysfunction.
References

Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top